Feed IDXX
ID
IDEXX Laboratories
IDXX · NASDAQ
$586.67 -0.18% (-$1.06)
1M +6.18%
Market Cap $46.5B
P/E Ratio 43.93x
Div. Yield -
ROE 68.56%
Bulios Fair Price
$360.74
38.5% downside
Current Price
$586.67
Undervalued Fair Value Overvalued
According to Bulios Fair Price, IDXX is currently overvalued relative to its market price. How does it work?
Valuation
9 /100
Expensive P/B 28.99x
P/S 10.81x
P/E 43.93x
Growth
82 /100
Growing Book val. growth 38.16%
FCF growth 38.77%
EPS growth 17.66%
Profitability
100 /100
Strong FCF margin 24.48%
Op. margin 31.60%
Gross margin 61.80%
Quality
100 /100
Excellent Asset turnover 1.28x
ROA 31.62%
ROIC 40.27%
Debt
82 /100
Low Net debt/EBITDA 0.61x
Int. coverage 35.61x
Debt/Equity 0.67x
Stability
82 /100
Stable Profitable years 6
EPS volatility 10.40%
Beta 1.55x
Ask StockBot about IDXX
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Michael Erickson
Employees
11,000
Headquarters
Westbrook
Upcoming events
02 NOV
Earnings
Upcoming earnings report